(Q34253275)

31 July 2017

title

Antiepileptic drugs and bone metabolism in children: data from 128 patients (English)

1 reference

31 July 2017

Peter Borusiak

1

1 reference

31 July 2017

Thorsten Langer

2

1 reference

31 July 2017

Marion Heruth

3

1 reference

31 July 2017

Michael Karenfort

4

1 reference

31 July 2017

Ulrich Bettendorf

5

1 reference

31 July 2017

Andreas C W Jenke

6

1 reference

31 July 2017

publication date

1 May 2012

1 reference

Journal of Child Neurology

31 July 2017

published in

1 reference

31 July 2017

volume

28

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

176-183

1 reference

Osteomalacia with Long-term Anticonvulsant Therapy in Epilepsy

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0883073812443005

Effect of antiepileptic drugs on bone density in ambulatory patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073812443005

Effect of antiepileptic medication on bone mineral measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073812443005

Antiepileptic drug use and rates of hip bone loss in older men: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073812443005

Pathophysiology of bone loss in patients receiving anticonvulsant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073812443005

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073812443005

Evaluation and measurement of bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073812443005

Incidence of five common fracture types in an institutional epileptic population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073812443005

Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073812443005

Effect of carbamazepine and valproate on bone mineral density

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073812443005

Bone mineral metabolism changes in epileptic children receiving valproic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073812443005

Effect of carbamazepine and valproate on bone mineral density

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073812443005

Analysis of the musculoskeletal system in children and adolescents receiving anticonvulsant monotherapy with valproic acid or carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073812443005

Adverse effects of antiepileptic drugs on bone mineral density in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073812443005

Chronic antiepileptic monotherapy, bone metabolism, and body composition in non-institutionalized children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073812443005

Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073812443005

Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073812443005

Bone mineral density in children, adolescents, and young adults with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073812443005

21 January 2018

Identifiers

DOI

10.1177/0883073812443005

1 reference

31 July 2017

1 reference